Author Correction: TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence

Puntos clave

• TRIM28-mediated modifications increase the virulence of SARS-CoV-2, enhancing its potential to cause disease.
• Key evidence shows that SUMOylation of the nucleocapsid protein alters viral behavior and pathogenicity in 2023.
• The observational analysis employs molecular techniques to examine nucleocapsid protein interactions and modifications.
• The findings underscore the need for further exploration of TRIM28's role in viral pathogenicity and potential therapeutic targets.